PainReform Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 7

Employees

  • Stock Symbol
  • PRFX

Stock Symbol

  • Share Price
  • $0.58
  • (As of Friday Closing)

PainReform General Information

Description

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 65 Yigal Alon Street
  • Po Box 68
  • Tel Aviv 6744316
  • Israel
+972
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Vertical(s)
Corporate Office
  • 65 Yigal Alon Street
  • Po Box 68
  • Tel Aviv 6744316
  • Israel
+972

PainReform Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PainReform Stock Performance

As of 08-Nov-2024, PainReform’s stock price is $0.58. Its current market cap is $1.3M with 2.23M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.58 $0.60 $0.43 - $20.16 $1.3M 2.23M 492K -$36.84

PainReform Financials Summary

As of 30-Jun-2024, PainReform has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV (2,629) (4,201) (8,567) (4,396)
Revenue 0 0 0 0
EBITDA (17,962) (9,727) (8,928) (7,233)
Net Income (17,673) (9,344) (8,792) (7,246)
Total Assets 3,107 9,930 12,328 19,073
Total Debt 59 86 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PainReform Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PainReform‘s full profile, request access.

Request a free trial

PainReform Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established t
Drug Discovery
Tel Aviv, Israel
7 As of 2023

Tampa, FL
 

Cupertino, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PainReform Competitors (2)

One of PainReform’s 2 competitors is Pacira BioSciences, a Formerly VC-backed company based in Tampa, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pacira BioSciences Formerly VC-backed Tampa, FL
Durect Formerly VC-backed Cupertino, CA
You’re viewing 2 of 2 competitors. Get the full list »

PainReform Patents

PainReform Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150148325-A1 Depot formulations of a hydrophobic active ingredient and methods for preparation thereof Active 10-May-2012
US-20150111923-A1 Depot formulations of a local anesthetic and methods for preparation thereof Active 10-May-2012
US-9849088-B2 Depot formulations of a hydrophobic active ingredient and methods for preparation thereof Active 10-May-2012
US-9668974-B2 Depot formulations of a local anesthetic and methods for preparation thereof Active 10-May-2012
US-20180049985-A1 Depot formulations of a local anesthetic and methods for preparation thereof Active 10-May-2012 A61K9/1277
To view PainReform’s complete patent history, request access »

PainReform Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PainReform FAQs

  • When was PainReform founded?

    PainReform was founded in 2007.

  • Where is PainReform headquartered?

    PainReform is headquartered in Tel Aviv, Israel.

  • What is the size of PainReform?

    PainReform has 7 total employees.

  • What industry is PainReform in?

    PainReform’s primary industry is Drug Discovery.

  • Is PainReform a private or public company?

    PainReform is a Public company.

  • What is PainReform’s stock symbol?

    The ticker symbol for PainReform is PRFX.

  • What is the current stock price of PainReform?

    As of 08-Nov-2024 the stock price of PainReform is $0.58.

  • What is the current market cap of PainReform?

    The current market capitalization of PainReform is $1.3M.

  • Who are PainReform’s competitors?

    Pacira BioSciences and Durect are competitors of PainReform.

  • What is PainReform’s annual earnings per share (EPS)?

    PainReform’s EPS for 12 months was -$36.84.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »